At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Triple-blind, Placebo Controlled, Parallel Clinical Trial to Investigate the Safety and Efficacy of D-Mannose on Symptoms of Urinary Tract Infection in Women
In Brief
A Phase 2 clinical trial evaluating UClear and Placebo for Urinary Tract Infection(UTI). Completed, enrolled 30 participants across 1 site.
Detailed Summary
The objective of this acute study was to investigate the safety and efficacy of UClear for the resolution of urinary tract infection (UTI) symptoms in women. The main questions it aims to answer is: 1. Is there a difference in proportion of participants with complete resolution of UTI symptoms at Day 4 between UClear and placebo 2. Is there a difference in change from baseline (Day 1) at Day 4 between UClear and placebo in Urinary Tract Infection Symptom Assessment (UTISA) symptom severity scores. Participants will take UClear or placebo twice a day for 3 days with or without food, have 4 in clinical visits, and will be instructed to complete a quality of life (QoL) questionnaire during each visit and a UTISA questionnaire at follow-up (Day 7).
Study Details
Timeline
Interventions
Take one dose twice a day for three days with or without food, starting on Day 1 (baseline visit).
Take one dose twice a day for three days with or without food, starting on Day 1 (baseline visit).